Fibrobiologics Inc (FBLG)

$0.54 -0.02 (-2.76%)
Market Cap 24.15M
Revenue (ttm) 0.00
Net Income (ttm) -11.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 9.38
Volume 347,150
Avg Vol 474,894
Day's Range N/A - N/A
Shares Out 39.68M
Stochastic %K 5%
Beta -0.74
Analysts Strong Sell
Price Target $10.75

Company Profile

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Industry: Biotechnology
Sector: Healthcare
Phone: 281-651-5150
Address:
455 East Medical Center Boulevard, Suite 300, Houston, United States
Cookem_up09
Cookem_up09 Aug. 6 at 1:30 PM
$FBLG trials should be coming later this year.
0 · Reply
Cookem_up09
Cookem_up09 Aug. 6 at 2:17 AM
$FBLG you guys have no idea what’s to come.
1 · Reply
Peace2026
Peace2026 Aug. 5 at 6:57 PM
$FBLG https://www.gurufocus.com/news/3034258/fibrobiologics-fblg-sees-price-target-raised-by-hc-wainwright-fblg-stock-news
0 · Reply
ZacksSCR
ZacksSCR Aug. 5 at 6:33 PM
$FBLG: Closes Third Tranche of $5M… https://buff.ly/uQ7TUwr
0 · Reply
MisoHawny
MisoHawny Aug. 5 at 6:04 PM
$FBLG every time the stock tanks they release a statement from the same two investment banks reiterating a “buy” with the same price target for the next 12 months. So it’s a perpetual 12 month “buy” rating from only to investment banks.
0 · Reply
Cookem_up09
Cookem_up09 Aug. 5 at 4:58 PM
$FBLG make it make sense.
0 · Reply
JarvisFlow
JarvisFlow Aug. 5 at 10:30 AM
HC Wainwright & Co. has adjusted their stance on FibroBiologics ( $FBLG ), setting the rating to Buy with a target price of 10 → 12.
1 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 12:00 PM
D. Boral Capital has updated their rating for FibroBiologics ( $FBLG ) to Buy with a price target of 16.
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 4 at 11:33 AM
$FBLG https://newsfilter.io/articles/d-boral-capital-maintains-buy-on-fibrobiologics-maintains-16-price-target-72d2d6f6a6fe2396622fbbdc1a29f0eb
0 · Reply
Cookem_up09
Cookem_up09 Aug. 1 at 7:04 PM
$FBLG files patent for methods of generating multipoint cells from donor tissue for clinical applications. Human trials soon??
0 · Reply
Latest News on FBLG
FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jul 31, 2025, 4:30 PM EDT - 5 days ago

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

Jul 28, 2025, 8:30 AM EDT - 9 days ago

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

FibroBiologics to Present at the Advanced Wound Care Summit USA

Jul 11, 2025, 8:30 AM EDT - 26 days ago

FibroBiologics to Present at the Advanced Wound Care Summit USA

FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank

Jul 9, 2025, 8:30 AM EDT - 4 weeks ago

FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank

FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

Jul 7, 2025, 4:35 PM EDT - 4 weeks ago

FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

Jun 16, 2025, 4:35 PM EDT - 7 weeks ago

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

FibroBiologics to Present at the BIO International Convention 2025

Jun 16, 2025, 9:50 AM EDT - 7 weeks ago

FibroBiologics to Present at the BIO International Convention 2025

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

Jun 9, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

May 16, 2025, 8:30 AM EDT - 2 months ago

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 14, 2025, 4:30 PM EDT - 2 months ago

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Presenting at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 3 months ago

FibroBiologics Presenting at the ThymUS 2025 Meeting

FibroBiologics Presents at the ThymUS 2025 Meeting

Apr 29, 2025, 9:15 AM EDT - 3 months ago

FibroBiologics Presents at the ThymUS 2025 Meeting

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

Apr 11, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

Apr 8, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

Apr 2, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 31, 2025, 4:25 PM EDT - 4 months ago

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces 2025 Annual Meeting of Stockholders

Mar 27, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics Announces 2025 Annual Meeting of Stockholders

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

Mar 21, 2025, 8:30 AM EDT - 4 months ago

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

Mar 4, 2025, 8:30 AM EST - 5 months ago

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

Feb 27, 2025, 8:30 AM EST - 5 months ago

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

Feb 5, 2025, 9:15 AM EST - 6 months ago

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Dec 30, 2024, 4:30 PM EST - 7 months ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

Dec 30, 2024, 2:12 PM EST - 7 months ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

FibroBiologics Announces $25 Million Financing

Dec 23, 2024, 7:55 AM EST - 8 months ago

FibroBiologics Announces $25 Million Financing

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Nov 19, 2024, 9:15 AM EST - 9 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Nov 14, 2024, 9:15 AM EST - 9 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024, 4:20 PM EST - 9 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

Oct 29, 2024, 9:15 AM EDT - 10 months ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

Oct 28, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

Oct 18, 2024, 8:30 AM EDT - 10 months ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

Oct 16, 2024, 9:15 AM EDT - 10 months ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

Sep 30, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

FibroBiologics Engages Southern Star Research as CRO in Australia

Sep 19, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics Engages Southern Star Research as CRO in Australia

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

Sep 12, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Aug 20, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

FibroBiologics Files 2024 Second Quarter Report

Aug 7, 2024, 6:52 PM EDT - 1 year ago

FibroBiologics Files 2024 Second Quarter Report

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

Jul 15, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Jun 25, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

FibroBiologics Set to Join Russell 2000® Index

Jun 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Set to Join Russell 2000® Index

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

Jun 6, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

FibroBiologics Announces 2024 Annual Meeting of Stockholders

May 15, 2024, 4:30 PM EDT - 1 year ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

FibroBiologics Files 2024 First Quarter Report

May 14, 2024, 5:24 PM EDT - 1 year ago

FibroBiologics Files 2024 First Quarter Report

FibroBiologics to Present at the BIO International Convention 2024

May 7, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at the BIO International Convention 2024

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

Apr 11, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

Apr 4, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

Mar 28, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

Mar 19, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

FibroBiologics to Present at Advanced Wound Care Summit USA

Mar 13, 2024, 9:31 AM EDT - 1 year ago

FibroBiologics to Present at Advanced Wound Care Summit USA

Cookem_up09
Cookem_up09 Aug. 6 at 1:30 PM
$FBLG trials should be coming later this year.
0 · Reply
Cookem_up09
Cookem_up09 Aug. 6 at 2:17 AM
$FBLG you guys have no idea what’s to come.
1 · Reply
Peace2026
Peace2026 Aug. 5 at 6:57 PM
$FBLG https://www.gurufocus.com/news/3034258/fibrobiologics-fblg-sees-price-target-raised-by-hc-wainwright-fblg-stock-news
0 · Reply
ZacksSCR
ZacksSCR Aug. 5 at 6:33 PM
$FBLG: Closes Third Tranche of $5M… https://buff.ly/uQ7TUwr
0 · Reply
MisoHawny
MisoHawny Aug. 5 at 6:04 PM
$FBLG every time the stock tanks they release a statement from the same two investment banks reiterating a “buy” with the same price target for the next 12 months. So it’s a perpetual 12 month “buy” rating from only to investment banks.
0 · Reply
Cookem_up09
Cookem_up09 Aug. 5 at 4:58 PM
$FBLG make it make sense.
0 · Reply
JarvisFlow
JarvisFlow Aug. 5 at 10:30 AM
HC Wainwright & Co. has adjusted their stance on FibroBiologics ( $FBLG ), setting the rating to Buy with a target price of 10 → 12.
1 · Reply
JarvisFlow
JarvisFlow Aug. 4 at 12:00 PM
D. Boral Capital has updated their rating for FibroBiologics ( $FBLG ) to Buy with a price target of 16.
0 · Reply
XkaliburTrading
XkaliburTrading Aug. 4 at 11:33 AM
$FBLG https://newsfilter.io/articles/d-boral-capital-maintains-buy-on-fibrobiologics-maintains-16-price-target-72d2d6f6a6fe2396622fbbdc1a29f0eb
0 · Reply
Cookem_up09
Cookem_up09 Aug. 1 at 7:04 PM
$FBLG files patent for methods of generating multipoint cells from donor tissue for clinical applications. Human trials soon??
0 · Reply
derider58
derider58 Aug. 1 at 2:30 PM
$FBLG Based on short shares... could see a gain today!
0 · Reply
Peace2026
Peace2026 Aug. 1 at 5:52 AM
$FBLG https://investorshangout.com/fibrobiologics-shares-growth-strategies-post-q2-2025-results-346729-/
0 · Reply
Peace2026
Peace2026 Aug. 1 at 5:51 AM
$FBLG https://investorshangout.com/fibrobiologics-shares-growth-strategies-post-q2-2025-results-346729-/
0 · Reply
derider58
derider58 Jul. 31 at 1:08 PM
$FBLG
0 · Reply
Cookem_up09
Cookem_up09 Jul. 30 at 6:44 PM
$FBLG hold and don’t put a stop loss on.
0 · Reply
derider58
derider58 Jul. 30 at 3:25 PM
$FBLG Looks like the shorts are covering!
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Jul. 30 at 2:30 PM
$FBLG My .60 wall did not hold up long. 30,000 shares and sinking woohoo. High risk gambling here based on analysts estimates
1 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Jul. 29 at 10:21 PM
$FBLG so the gamble is 1/2 results in 2026. Cash runs out pretty soon
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Jul. 29 at 6:05 PM
$FBLG Inthink ChatGPT told me wrong. Is there interim data coming out soon? Looks like they just starting to kick off a trial
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor Jul. 29 at 4:28 PM
$FBLG I’m the idiot that just bought 9500 shares.
2 · Reply
MrTicker
MrTicker Jul. 29 at 1:19 PM
$FBLG D. Boral Capital Maintains Buy on FibroBiologics, Maintains $16 Price Target BENZINGA 8:16 AM ET 7/29/2025
0 · Reply
JarvisFlow
JarvisFlow Jul. 29 at 1:16 PM
D. Boral Capital updates rating for FibroBiologics ( $FBLG ) to Buy, target set at 16.
0 · Reply